SPX
0.003
50%
CHRCA
0.003
-86.4%
HWK
0.032
45.5%
OVT
0.002
-50%
APCR
0.004
33.3%
TMB
0.046
-30.3%
FBR
0.004
33.3%
ROG
0.003
-25%
RKB
0.004
33.3%
KLV
0.007
-22.2%
RHY
0.11
32.5%
SMX
0.019
-20.8%
VMS
0.165
26.9%
OB1
0.017
-19%
CYQ
0.005
25%
SNG
0.094
-18.3%
MRQ
0.005
25%
NES
0.005
-16.7%
PGY
0.005
25%
TEM
0.005
-16.7%
SIS
0.005
25%
USC
0.01
-16.7%
VEN
0.005
25%
GLL
0.006
-14.3%
HE8
0.011
22.2%
PLC
0.006
-14.3%
HRE
0.044
22.2%
WNX
0.125
-13.8%
PKP
0.023
21.1%
AXI
0.013
-13.3%
BNL
0.006
20%
NRX
0.013
-13.3%
DWG
0.054
20%
HVY
0.505
-12.9%
MBK
0.025
19%
AM5
0.007
-12.5%
EWC
0.045
18.4%
DBO
0.021
-12.5%
HZR
0.485
18.3%
TAS
0.021
-12.5%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AVITA Medical (ASX:AVH) signed an exclusive 5 year distribution agreement with Stedical Scientific

AVITA Medical (ASX:AVH) signed an exclusive five year distribution agreement with Stedical Scientific, to commercialise PermeaDerm® Biosynthetic Wound Matrix in the U.S. The matrix is cleared by the U.S. FDA and used for a variety of injuries | https://announcements.asx.com.au/asxpdf/20240111/pdf/05zbp446ftpyw0.pdf #FDA #PermeaDerm #AVH